| Mrs Dorian D'shan Jackson, MSN, APN-C | |
|
1010 Haddonfield Berlin Rd Ste 400, Voorhees, NJ 08043-3514 | |
| (856) 435-7007 | |
| (856) 435-4372 |
| Full Name | Mrs Dorian D'shan Jackson |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 20 Years |
| Location | 1010 Haddonfield Berlin Rd Ste 400, Voorhees, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003098633 | NPI | - | NPPES |
| 0226254 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 26NO12442500 (New Jersey) | Secondary |
| 363LX0001X | Nurse Practitioner - Obstetrics & Gynecology | 26NJ00070500 (New Jersey) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Virtua Medical Group, Pa | 9830222397 | 1226 |
News Archive
Lightlake Therapeutics Inc., an early stage biopharmaceutical company developing modern addiction treatments based on its expertise using opioid antagonists, announced today that it intends to develop a treatment for premenstrual syndrome (PMS) overeating using its patented technology involving opioid antagonists.
Innovex, a Quintiles company, and Healthcare at Home today announced that they have agreed to form an innovative healthcare joint venture in Europe, named Healthcare at Home Europe.
UST Global, a leading provider of information technology services and solutions for Global 1000 companies, today unveiled its plans to enter the burgeoning market of patient-centered health information. It will provide a palette of services based on the Blue Button initiative. UST Global also announced a strategic alliance with Amida Technology Solutions of Silver Spring, Maryland.
Current research suggests that T helper-type 1 (Th1) cells, previously thought to mediate autoimmunity, may actual inhibit the development of experimental immune encephalomyelitis (EAE), a mouse model of multiple sclerosis (MS), by suppressing Th17 cells.
› Verified 5 days ago
| Entity Name | Camcare Health Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790857696 PECOS PAC ID: 2567365117 Enrollment ID: O20040130000243 |
News Archive
Lightlake Therapeutics Inc., an early stage biopharmaceutical company developing modern addiction treatments based on its expertise using opioid antagonists, announced today that it intends to develop a treatment for premenstrual syndrome (PMS) overeating using its patented technology involving opioid antagonists.
Innovex, a Quintiles company, and Healthcare at Home today announced that they have agreed to form an innovative healthcare joint venture in Europe, named Healthcare at Home Europe.
UST Global, a leading provider of information technology services and solutions for Global 1000 companies, today unveiled its plans to enter the burgeoning market of patient-centered health information. It will provide a palette of services based on the Blue Button initiative. UST Global also announced a strategic alliance with Amida Technology Solutions of Silver Spring, Maryland.
Current research suggests that T helper-type 1 (Th1) cells, previously thought to mediate autoimmunity, may actual inhibit the development of experimental immune encephalomyelitis (EAE), a mouse model of multiple sclerosis (MS), by suppressing Th17 cells.
› Verified 5 days ago
| Entity Name | Regional Womens Health Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548215536 PECOS PAC ID: 2961316328 Enrollment ID: O20040420000034 |
News Archive
Lightlake Therapeutics Inc., an early stage biopharmaceutical company developing modern addiction treatments based on its expertise using opioid antagonists, announced today that it intends to develop a treatment for premenstrual syndrome (PMS) overeating using its patented technology involving opioid antagonists.
Innovex, a Quintiles company, and Healthcare at Home today announced that they have agreed to form an innovative healthcare joint venture in Europe, named Healthcare at Home Europe.
UST Global, a leading provider of information technology services and solutions for Global 1000 companies, today unveiled its plans to enter the burgeoning market of patient-centered health information. It will provide a palette of services based on the Blue Button initiative. UST Global also announced a strategic alliance with Amida Technology Solutions of Silver Spring, Maryland.
Current research suggests that T helper-type 1 (Th1) cells, previously thought to mediate autoimmunity, may actual inhibit the development of experimental immune encephalomyelitis (EAE), a mouse model of multiple sclerosis (MS), by suppressing Th17 cells.
› Verified 5 days ago
| Entity Name | Virtua Medical Group, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649226515 PECOS PAC ID: 9830222397 Enrollment ID: O20100804000338 |
News Archive
Lightlake Therapeutics Inc., an early stage biopharmaceutical company developing modern addiction treatments based on its expertise using opioid antagonists, announced today that it intends to develop a treatment for premenstrual syndrome (PMS) overeating using its patented technology involving opioid antagonists.
Innovex, a Quintiles company, and Healthcare at Home today announced that they have agreed to form an innovative healthcare joint venture in Europe, named Healthcare at Home Europe.
UST Global, a leading provider of information technology services and solutions for Global 1000 companies, today unveiled its plans to enter the burgeoning market of patient-centered health information. It will provide a palette of services based on the Blue Button initiative. UST Global also announced a strategic alliance with Amida Technology Solutions of Silver Spring, Maryland.
Current research suggests that T helper-type 1 (Th1) cells, previously thought to mediate autoimmunity, may actual inhibit the development of experimental immune encephalomyelitis (EAE), a mouse model of multiple sclerosis (MS), by suppressing Th17 cells.
› Verified 5 days ago
| Entity Name | Vmd Primary Providers Of New Jersey Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952992455 PECOS PAC ID: 6608284674 Enrollment ID: O20210413001435 |
News Archive
Lightlake Therapeutics Inc., an early stage biopharmaceutical company developing modern addiction treatments based on its expertise using opioid antagonists, announced today that it intends to develop a treatment for premenstrual syndrome (PMS) overeating using its patented technology involving opioid antagonists.
Innovex, a Quintiles company, and Healthcare at Home today announced that they have agreed to form an innovative healthcare joint venture in Europe, named Healthcare at Home Europe.
UST Global, a leading provider of information technology services and solutions for Global 1000 companies, today unveiled its plans to enter the burgeoning market of patient-centered health information. It will provide a palette of services based on the Blue Button initiative. UST Global also announced a strategic alliance with Amida Technology Solutions of Silver Spring, Maryland.
Current research suggests that T helper-type 1 (Th1) cells, previously thought to mediate autoimmunity, may actual inhibit the development of experimental immune encephalomyelitis (EAE), a mouse model of multiple sclerosis (MS), by suppressing Th17 cells.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Dorian D'shan Jackson, MSN, APN-C 301 Lippincott Drive Suite 410, New York, NY 10087-0001 Ph: (856) 355-0340 | Mrs Dorian D'shan Jackson, MSN, APN-C 1010 Haddonfield Berlin Rd Ste 400, Voorhees, NJ 08043-3514 Ph: (856) 435-7007 |
News Archive
Lightlake Therapeutics Inc., an early stage biopharmaceutical company developing modern addiction treatments based on its expertise using opioid antagonists, announced today that it intends to develop a treatment for premenstrual syndrome (PMS) overeating using its patented technology involving opioid antagonists.
Innovex, a Quintiles company, and Healthcare at Home today announced that they have agreed to form an innovative healthcare joint venture in Europe, named Healthcare at Home Europe.
UST Global, a leading provider of information technology services and solutions for Global 1000 companies, today unveiled its plans to enter the burgeoning market of patient-centered health information. It will provide a palette of services based on the Blue Button initiative. UST Global also announced a strategic alliance with Amida Technology Solutions of Silver Spring, Maryland.
Current research suggests that T helper-type 1 (Th1) cells, previously thought to mediate autoimmunity, may actual inhibit the development of experimental immune encephalomyelitis (EAE), a mouse model of multiple sclerosis (MS), by suppressing Th17 cells.
› Verified 5 days ago
Ms. Kristi A. Kennedy, WHNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 900 Centennial Blvd Ste M, Voorhees, NJ 08043 Phone: 855-632-2667 | |
Rachana U Cammarata, ANP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2301 E Evesham Rd Ste 505, Voorhees, NJ 08043 Phone: 856-520-8718 Fax: 856-520-8719 | |
James Mcgee, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 30 Battery Hill Dr, Voorhees, NJ 08043 Phone: 856-340-9099 | |
Michelle Sheel, MSN, APN, C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 200 Bowman Dr, Suite E, Voorhees, NJ 08043 Phone: 856-751-7880 | |
Heather Ann Rozencwaig, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 200 Bowman Dr, Suite D285, Voorhees, NJ 08043 Phone: 856-602-4000 Fax: 856-947-1747 | |
Meryl Penalver, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 200 Bowman Dr Ste E340, Voorhees, NJ 08043 Phone: 856-247-7600 Fax: 856-247-7575 | |
Mrs. Retha Jennifer Randall, APN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1012 Laurel Oak Rd, Voorhees, NJ 08043 Phone: 856-435-7502 Fax: 856-627-2183 |